Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Chem Biol Interact ; 157-158: 401-4, 2005 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-16429536

RESUMEN

The main factor of Alzheimer disease (AD) is beta-amyloid peptide (Abeta). It is known to affect acetylcholinesterase (AChE) through lipid peroxidation (LPO) initiated with H2O2 which is formed as a result of Abeta activity. The direct action of H2O2 on the enzyme is also possible. For membrane bound AChE of erythrocytes we observed inhibition under H2O2 action which was replaced by activation at small H2O2 concentrations. At higher substrate concentrations the inversion of the effect came at smaller concentrations of H2O2. For soluble erythrocytic AChE inhibition took place (caused by Km increase). Soluble enzyme from Electric Eel revealed inhibition, which was not replaced by activation at any concentration of peroxide. Low H2O2 concentrations caused intensification of lipid peroxidation in microsomes. The magnitude of the changes in LPO rate was within the range of the changes, where LPO system fulfills the control function for cell metabolism. With the help of ESR technique of spin probes it was found the rigidization under H2O2 action of close to surface area of lipid bilayer in erythrocytic and brain cell membranes. Summing up we can say that H2O2 modifies membrane structure and activity of AChE. Whether or not it will contribute to AD pathogenesis or is the manifestation of compensatory processes-the possible subject of discussion and further investigation.


Asunto(s)
Acetilcolinesterasa/metabolismo , Membrana Celular/efectos de los fármacos , Membrana Celular/enzimología , Peróxido de Hidrógeno/farmacología , Animales , Encéfalo/efectos de los fármacos , Encéfalo/enzimología , Membrana Celular/química , Electrophorus , Activación Enzimática/efectos de los fármacos , Humanos , Hidrólisis/efectos de los fármacos , Cinética , Peroxidación de Lípido/efectos de los fármacos , Ratones , Viscosidad
2.
J Cancer Res Ther ; 6(1): 47-53, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20479547

RESUMEN

CONTEXT: Increased oxidative stress is a significant part of pathogenesis of smoking-related cancer. AIM: The study aims to investigate changes in antioxidant status induced by chronic cigarette smoking in cancer patients and healthy subjects. SETTING AND DESIGN: We examined the venous blood samples of 54 healthy subjects, both smokers (25) and non-smokers and of 50 patients with smoking-related cancer, both smokers (34) and non-smokers. MATERIALS AND METHODS: We measured the activities of five antioxidant (AO) enzymes: glutathione peroxidase, glutathione transferase (GST), glutathione reductase, superoxide dismutase and catalase in the blood of 50 cancer patients and 54 healthy persons. Damage to cellular structures (level of malonic dialdehyde, micro viscosity of erythrocyte membranes, number of leukocyte DNA breaks) was determined. Statistical analysis of results obtained was performed using conventional and multi-factorial statistical methods. RESULTS: Statistically significant increase in GST activity and DNA breaks, but decrease of membranes micro viscosity in cancer patients, compared with healthy subjects were obtained. In the cancer patients, no influence of smoking on studied parameters was found. Correlations of parameters within cancer patients and healthy subjects group did not coincide with each other. CONCLUSIONS: Changes of AO status parameters and oxidative damages in cell structures are related to tumor processes indicating the augmentation of oxidative stress in human blood. This study demonstrated potential applicability of a statistical model based on the evaluated biomarkers of oxidative stress to determine a smoking-induced harm of cancer incidence in healthy subjects.


Asunto(s)
Antioxidantes/análisis , Biomarcadores de Tumor/sangre , Roturas del ADN , Neoplasias/sangre , Estrés Oxidativo/fisiología , Fumar/efectos adversos , Biomarcadores de Tumor/genética , Catalasa/sangre , Membrana Celular/patología , Eritrocitos/patología , Glutatión Peroxidasa/sangre , Glutatión Reductasa/sangre , Glutatión Transferasa/sangre , Humanos , Persona de Mediana Edad , Neoplasias/genética , Superóxido Dismutasa/sangre
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA